Search

Avita raises $10m for ReCell rollout

Regenerative medicine company Avita Medical has raised $10 million from investors to support the commercialisation of its ReCell device, which is being trialled by a US government agency.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 31/10/18

1 year TSR5 year TSR
55thAvita Medical90%-1%
97thI Synergy Group52%0%
232ndMustera Property Group16%0%
293rdKatana Capital5%4%
630thAdmedus-43%-38%
744 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

29/12/17
$75k Bought
29/12/17
$10k Bought
28/12/17
$5k Bought
Total value as at the date of the transaction
Source: Morningstar

Revenue

84th↓Admedus$11.7m
85th↑Mustera Property Group$11.4m
86th↑Avita Medical$11.3m
87th↑I Synergy Group$10.8m
88th↑Katana Capital$10.3m
239 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer